American Society of Hirudotherapy

Chronic Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)

Investigational for category III CP/CPPS: evidence is limited to a 3-patient case report, an uncontrolled Russian series and a comparison in urogenital infection; multimodal therapy remains standard.

Tier C — InvestigationalInvestigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Last Updated: November 17, 2026 · ASH Editorial · based on the books

Patient Summary

Is this FDA-cleared for this use?
Not FDA-cleared for chronic prostatitis / CPPS. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use for CP/CPPS is investigational.
What evidence exists?
Tier C (investigational). A 3-patient case report (Trak 2023) and an uncontrolled Russian observation of 151 patients (Savinov and Kuchersky 1998) were identified, and a Russian medical book also describes a comparison in urogenital infection that included men with chronic prostatitis, without separate results for them (see “What the books describe” below); no controlled study shows that leech therapy helps in chronic prostatitis. CP/CPPS (category III, chronic non-bacterial prostatitis) is multifactorial and best managed with a UPOINT-based multimodal approach: alpha-blockers, pelvic floor physiotherapy (often the highest-yield intervention), neuropathic pain agents, lifestyle changes, and addressing psychological / sexual / urinary symptom domains. Acute bacterial prostatitis is a distinct condition requiring antibiotics.
Main risks
  • Bleeding from bite sites for 6 to 24 hours after detachment in the perineum and lower abdomen
  • Bruising and tenderness in the perineum, sacrum, or suprapubic area for 5 to 10 days
  • Local skin infection or, rarely, Aeromonas infection
  • Allergic reaction to leech saliva (uncommon)
  • Temporary worsening of pelvic pain or urinary symptoms for 1 to 3 days
  • Small bite marks that usually fade over weeks to months (rarely a pale spot stays longer)
  • Delay or replacement of pelvic floor physiotherapy and multimodal management
  • Missed Category I or II (bacterial) prostatitis if culture-guided antibiotics have not been considered
Who should not consider this
  • Patients with acute bacterial prostatitis (urinary infection, fever, severe pelvic pain — needs antibiotics)
  • Patients with prostate cancer on active surveillance or recent biopsy
  • Patients on anticoagulants, with hemophilia, or with anemia
  • Patients with active perianal or genital infection
  • Patients who have not been evaluated for UPOINT domains (urinary, psychosocial, organ-specific, infection, neurologic / systemic, tenderness)
  • Patients who have not tried pelvic floor physiotherapy with a qualified pelvic specialist
  • Patients with NIH Category I (acute) or Category II (chronic bacterial) prostatitis (antibiotics first)
  • Patients with active urinary tract infection
  • Patients with perineal skin breakdown
What to ask your clinician
  • Has acute bacterial prostatitis been excluded with urinalysis and culture?
  • Have I had a UPOINT phenotype evaluation, and what is my primary symptom domain?
  • Have I tried pelvic floor physiotherapy — the highest-evidence intervention?
  • Have I tried alpha-blockers (tamsulosin), and have neuropathic pain agents been considered?
  • Has central sensitization or psychological component been addressed (CBT, mindfulness)?
  • What is the practitioner's experience and Aeromonas-prevention plan? Will leeches be placed near genitalia or rectum?
  • What is the realistic chance of benefit and the cost?
When to seek urgent care
  • Fever, severe pelvic pain, inability to urinate, or visible blood in urine (acute bacterial prostatitis — urgent care)
  • Sudden severe testicular pain or swelling (torsion or epididymitis)
  • New constipation, bowel or bladder dysfunction, or saddle anesthesia (cauda equina — call 911)
  • Spreading redness, warmth, pus, or red streaks (cellulitis)
  • Bleeding from a bite site lasting more than 24 to 48 hours
  • Fever above 38.0 C / 100.4 F or chills
  • Hives, throat tightness, or breathing difficulty
  • Visible blood in urine or perineal hematoma

What this does NOT mean

  • This is not FDA-cleared for chronic prostatitis or CPPS.
  • Unblinded case series with high placebo-response potential do NOT establish efficacy versus multimodal care.
  • Mechanism rationale (pelvic floor decongestion) does NOT replace pelvic floor physiotherapy.
  • Leech therapy is not a substitute for UPOINT-based multimodal management.
  • Acute bacterial prostatitis is a distinct condition that requires antibiotics, NOT complementary therapy.

Clinical Profile

Category
Urogenital
ICD-10
N41.1, N41.9, N50.819
Safety tier
Medium

Evidence Summary

No controlled clinical trial of leech therapy for category III chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) was identified in PubMed, Europe PMC, Crossref or ClinicalTrials.gov. The clinical evidence located includes a report of 3 patients (Trak et al. 2023; visual analogue scale pain fell from 9 to 3-4 and NIH-CPSI scores improved by 31-79%) and an uncontrolled Russian observation of 151 patients with chronic prostatitis who received leeches alongside conventional treatment (Savinov and Kuchersky 1998, as summarized in Baskova and Isakhanyan 2004; no quantitative outcomes given). Baskova and Isakhanyan (2004) also retell a comparison in urogenital infection that included men with chronic prostatitis, in which leeches were added to antimicrobial treatment; results for the men with prostatitis are not given separately (see “What the books describe” below). Any use is investigational. Leeches must NEVER be placed intra-rectally or peri-prostatically. A proposed mechanism involves pelvic-floor decongestion and modulation of central pain sensitization, but this is unproven. CP/CPPS is multifactorial and best managed with a UPOINT-based multimodal approach (alpha-blockers, pelvic-floor physical therapy, neuromodulators, lifestyle measures). Leech therapy could only be considered as an unproven exploratory adjunct.

What the books describe

Below is a summary of what books on hirudotherapy say about this condition. These are the authors’ observations, not a proven effect and not a promise of results. Hirudotherapy has contraindications; the decision is made by a physician.

  • Baskova and Isakhanyan name chronic prostatitis among the diseases for which, according to their list, treatment with leeches is recommended[B1].
  • They retell an observation by Savinov and Kucherskiy (1998): 151 patients with chronic prostatitis (and 209 patients with prostate adenoma) received leeches in addition to the usual treatment; the effect was assessed by clinical signs, blood clotting, immunological and hormonal indicators and microscopy of the prostatic secretion, and the retelling says that the method “proved effective,” the drainage function of the gland improved and the number of cures increased[B1].
  • In Baskova and Isakhanyan’s retelling there are no numbers (how many patients improved or were cured), no comparison group is named for this result, it is not stated whether the patients had bacterial prostatitis or not, and the term “chronic pelvic pain syndrome” does not appear in the book; the book does not distinguish between forms of chronic prostatitis.
  • Baskova and Isakhanyan call V. A. Savinov a consistent advocate of leeches in urology, but in another chapter they agree with criticism according to which the technologies proposed by him (among other authors) “do not withstand any criticism” from the standpoint of “true naturopathy” and the principle “do no harm” (whether this applies to his urological method is not clear from the text), and in the chapter on contraindications they write that prescribing leeches “in large numbers, for long periods, with no or only short breaks” is unjustified and impermissible[B1].
  • Michalsen et al. do not write about prostatitis.
  • Both books name hemophilia, taking anticoagulants (medicines that affect blood clotting) and anemia as contraindications: Baskova and Isakhanyan include them in their general list of contraindications, while Flecken and Michalsen, in the chapter on contraindications, call hemophilia and anticoagulants an absolute contraindication and regard treatment involving blood loss as generally contraindicated in anemia; this is only part of the contraindications listed in the books[B1][B3].
  • Baskova and Isakhanyan advise refraining from hirudotherapy when body temperature is high, and Flecken and Michalsen write that in the acute stages of infectious diseases leech treatment, according to experience, can cause a feeling of weakness and impair wound healing, and that in the broader concepts of naturopathy and humoral pathology any treatment that extracts blood from patients with infectious diseases is considered counterproductive and is not recommended[B1][B3].

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)

Contraindications

  • Hemophilia or another bleeding disorder
  • Taking anticoagulants (blood thinners such as warfarin or heparin)
  • Anemia or suppressed blood formation
  • Low blood pressure, shock, collapse or fainting
  • Severe wasting (cachexia)
  • Intolerance of leeches or a history of severe allergic reactions
  • Pregnancy
  • Stomach or duodenal ulcer, erosive gastritis
  • Acute infectious disease or high fever
  • Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
  • Drinking alcohol at the time of treatment
  • No consent from the patient
  • Acute bacterial prostatitis
  • Prostate cancer under active surveillance
  • NIH Category I/II prostatitis (bacterial — antibiotics first)
  • Active urinary tract infection
  • Recent prostate biopsy (<6 weeks)
  • Perineal skin breakdown

Related Conditions

References

  • [B1]

    Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]

    Москва: Монолит(2004)https://search.rsl.ru/ru/record/01007959553

    Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.

  • [B3]

    Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy

    Stuttgart — New York: Thieme(2007)https://books.google.com/books?vid=ISBN9781588905635

    ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.

The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.